SynthesisMultiple sclerosis and related disorders2025
Racial and ethnic disparities in pediatric autoimmune encephalitis: A systematic review.
Synthesis in Multiple sclerosis and related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phenotypic Diversity and Outcomes in Pediatric NMDA Receptor Encephalitis: A 15-Year Retrospective Study from the Largest Children's Hospital in the United States.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesHealth disparities and social determinants of health are increasingly recognized as important predictors for clinical outcomes in autoimmune disease. However, this is poorly studied in pediatric autoimmune encephalitis (AE).
methodsWe conducted a systematic literature review in accordance with PRISMA guidelines. Searches included Medline (Pubmed), EMBASE, and Web of Science databases from inception years to October 4, 2024. Inclusion criteria were: 1) Patients diagnosed with AE ≤ 18 years old; 2) any report of race and/or ethnicity, 3) report of specific diagnostics and disease outcomes, 4) observational cohort studies, epidemiological studies or case series/ cohort studies of n ≥ 5 participants. We excluded studies describing only AE associated with viral encephalitis, case reports or case series with <5 cases, papers without clear racial or ethnicity demographics, no report of clinical outcomes, and non-English studies. Study screening, scoring, and data extraction used the Covidence platform. Study quality utilized the Newcastle-Ottawa scale for case-control and cohort studies, and the Joanna Briggs Institute Critical Appraisal Checklist for epidemiological studies. Descriptive analyses were used to summarize study findings.
resultsA total of 35 studies were included in the study: 74 % retrospective cohort, 14 % prospective cohort, 8.6 % epidemiological, and 1 case-control study. Study quality fell mostly into "good" (45.7 %) or "fair" (37 %), and the remaining 17 % were given "poor" quality scores. Among the included studies, 94 % of the studies had pediatric-specific data from which demographic and clinical information could be extracted. Only 12 (34 %) of studies reported outcomes specific to a racial and/or ethnic group - 7 cohort studies from homogenous populations, 3 epidemiological studies, and 2 reported racial frequencies in cognitive outcomes only. No studies compared clinical outcomes among different racial or ethnic groups. DISCUSSION: There is an overall paucity in rigorous studies on health disparities in pediatric AE. Future studies should be aimed at determining individual, social, and structural risk factors that may impact treatment and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.